- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.03. | Blackstone to Fund up to $750M for Moderna's Flu Program | ||
| 27.03. | Lonza Expands Spray-Drying Services for Protein-Based Inhaled Therapies | ||
| 27.03. | ProBioGen Partners with DIOSynVax to Manufacture Trivalent Hemorrhagic Fever Vaccine | ||
| 26.03. | BioNTech Faces NIH Heat: Notice of Default Issued Over COVID-19 Vaccine Royalties | ||
| 26.03. | EPNextS Group and Frontage Labs Partner to Address 'Drug Lag' & 'Drug Loss' in Japan | ||
| 26.03. | Veeda Clinical Research Acquires European CRO, Heads | ||
| 26.03. | Exothera Launches Nucleic Acids Service Offering Powered by Ntensify | ||
| 26.03. | AstraZeneca's Ultomiris Approved by FDA for the Treatment of Adults with NMOSD | ||
| 25.03. | Olon Celebrates 10 Years of Daptomycin | ||
| 25.03. | Johnson & Johnson's Nipocalimab Earns Breakthrough Therapy Designation from FDA | ||
| 25.03. | AbbVie's ELAHERE Granted Full Approval by FDA for Ovarian Cancer | ||
| 25.03. | Altamira, Univercells Partner on Nanoparticle-Delivered mRNA Vaccines | ||
| 25.03. | Andelyn Biosciences Partners with Grace Science to Advance GS-100 | ||
| 25.03. | Novo Nordisk Agrees to Acquire Cardior Pharmaceuticals | ||
| 25.03. | AbbVie Agrees to Acquire Landos Biopharma | ||
| 22.03. | Ex-Prometheus Executives Launch Mirador Therapeutics | ||
| 22.03. | Italfarmaco S.p.A.'s Duvyzat Approved by FDA | ||
| 21.03. | Qosina Names David Oh to Represent Korean Market | ||
| 21.03. | Idorsia's TRYVIO Approved by FDA for the Treatment of Hypertension | ||
| 21.03. | Batavia and Candel Partner to Accelerate Development of CAN-3110 | ||
| 21.03. | Charles River Extends Gene Therapy Alliance with NUS Medicine | ||
| 20.03. | BioNTech 4Q Earnings Hit by Drop in Covid Vax Sales | ||
| 20.03. | BioNTech Appoints Annemarie Hanekamp Chief Commercial Officer | ||
| 20.03. | Tonix Pharmaceuticals Selects 2 CMOs to Support Tonmya in the U.S. | ||
| 20.03. | Novo Nordisk to Invest $566M in Tianjin, China Facility |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
